# Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)

> **NCT00201461** · PHASE2,PHASE3 · UNKNOWN · sponsor: **NMT Medical** · enrollment: 900 (estimated)

## Conditions studied

- Patent Foramen Ovale
- Stroke
- Ischemic Attack, Transient

## Interventions

- **DEVICE:** STARFlex septal closure system
- **DRUG:** Best medical therapy

## Key facts

- **NCT ID:** NCT00201461
- **Lead sponsor:** NMT Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2010-04
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2008-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201461, "Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00201461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*